A subsequent study in a Belgian FTD cohort identified a familial FTD patient with a distinct truncation mutation CHMP2BQ165X that leads to the loss of the final 49 amino acids, providing further evidence that C-terminal truncations of CHMP2B lead to FTD [20, 41]. The gene discussed is CHMP2B; the disease is frontotemporal dementia.